site map  

 

 

 

 

 

 

 


QUESTIONS?

+1 (802) 878-1777

hti@haemtech.com


 

 

 

 

 

 

 

 

ORDERING

Human Proteins

Bovine Proteins

Mouse Proteins

Other Species

Inhibitors

Substrates

Antibodies

Sample Collection Tubes

Deficient Plasmas

Assay Kits

Pricing

HOME PAGE

 

 

 

 

 

 

 

 

QUESTIONS?

+1 (802) 878-1777

hti@haemtech.com

Plasminogen

HUMAN PLASMINOGEN The domain structure of human plasminogen is represented where: K1-K5 = the 5 kringle domains, B-CHAIN = catalytic domain of plasmin , and the arrows indicate the sites of proteolytic cleavage by plasmin, elastase, and plasminogen activators (PA'S).

 

 

 

PURCHASING AND PRODUCT INFORMATION

 

Catalog Number

HCPG-0130

HCPG-0131

HCPG-0132

HCPG-0133

BCPG-1130

MCPG-5130*

Description

Human glu-Plasminogen

Human glu-Plasminogen CHOI

Human glu-Plasminogen CHOII

Human lys-Plasminogen

Bovine glu-Plasminogen

Mouse glu-Plasminogen

Size

1 milligram

1 milligram

1 milligram

1 milligram

1 milligram

100 µg

Formulation

50% (vol/vol) glycerol/H2O

50% (vol/vol) glycerol/H2O

50% (vol/vol) glycerol/H2O

50% (vol/vol) glycerol/H2O

50% (vol/vol) glycerol/H2O

50% (vol/vol) glycerol/H2O

Storage

-20oC

Purity

>95% by SDS-PAGE

Activity Determination

< 10 ppm plasmin activity for glu-PG

Shelf Life (properly stored)

12 months

 

Sample SDS-PAGE

Lane 1: Human Glu-Plasminogen (HCPG-0130) Reduced

Lane 2: Human Glu-Plasminogen CHOI (HCPG-0131) Reduced

Lane 3: Human Glu-Plasminogen CHOII (HCPG-0132) Reduced

Lane 4: Human Lys-Plasminogen (HCPG-0133) Reduced

Marker: See Blue +2_MOPS

Lane 5: Human Glu-Plasminogen (HCPG-0130) Non-Reduced

Lane 6: HumanGlu-Plasminogen CHOI (HCPG-0131)   Non-Red

Lane 7: Human Glu-Plasminogen CHOII (HCPG-0132) Non-Red

Lane 8: Human Lys-Plasminogen (HCPG-0133) Non-Reduced

Gel: Novex 4-12% Bis-Tris

Load: 1 µg per lane

Buffer: MOPS

Standard: SeeBluePlus 2; Myosin (191 kDa), Phosphorylase B (97 kDa), BSA (64 kDa), Glutamic Dehydrogenase (51 kDa), Alcohol Dehydrogenase (39 kDa), Carbonic Anhydrase (28 kDa), Myoglobin Red (19 kDa), Lysozyme (14 kDa)

Sample publications referencing our Plasminogen:

  1. Zaas AK, Liao G, Chien JW, Weinberg C, Shore D, et al. (2008) Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis. PLoS Genet 4(6): e1000101.doi:10.1371/journal.pgen.1000101 (mouse plasminogen)

This publication list is not all encompassing, and is only meant to provide limited examples of how Haematologic Technologies' products are used.  We encourage you to search the literature for other examples pertinent to your experimentation, and to contact us with any technical questions.

U.S. Pricing

Product inquiry

SAMPLE DATA SHEET

ORDER NOW!

*Due to mouse plasma quality issues our mouse proteins are not being sold until further notice.  At the present time we cannot give a completion date.  Thank you.

 

Overview of Plasminogen

Plasminogen is a single chain glycoprotein zymogen which is synthesized in the liver and circulates in plasma at a concentration of approximately 2.4 µM (1,2). The plasminogen molecule contains 790 amino acids, 24 disulfide bridges, no free sulfhydryls and 5 regions of internal sequence homology, known as kringles, between Lys77 and Arg560. These five triple-looped, three disulfide bridged, kringle regions are homologous to the kringle domains in t-PA, u-PA and prothrombin. Plasminogen contains one high affinity (Kd=9x10-6M) and four low affinity (Kd=5x10-3M) lysine binding sites. The high affinity binding site resides within the first kringle region of plasminogen. The interaction of plasminogen with fibrin and α2-antiplasmin is mediated by these lysine binding sites. Native glu-plasminogen (Mr=88,000) is readily converted to Lys-77-plasminogen (Mr=83,000) by plasmin hydrolysis of the Lys76-Lys77 peptide bond. Elastase catalyzed cleavage of the Val441-Val442 peptide bond of glu-plasminogen yields a functionally active zymogen termed Val-442 plasminogen or mini-plasminogen. 

The conversion of plasminogen to plasmin occurs by a variety of mechanisms, but all result in hydrolysis of the Arg560-Val561 peptide bond of plasminogen, yielding two chains which remain covalently associated by a disulfide bond. 

Native glu-plasminogen is prepared from fresh frozen human plasma by a modification of the procedure of Castellino (3), utilizing gel filtration and affinity chromatography. The two carbohydrate variants of glu-plasminogen (CHOI and CHOII) are isolated by gradient elution from lysine-Sepharose using the lysine analog, e-aminocaproic acid (3). The plasminogen is supplied in 50% (vol/vol) glycerol/H2O for storage at -20oC. Purity is determined by SDS-PAGE analysis. 

Properties of Plasminogen

Localization: Plasma
Plasma concentration: 2.4 µM (human) (4)
Mode of action: Zymogen; precursor to the serine protease plasmin
Molecular weight: 88,000 (glu plasminogen) (5)
83,000 (lys-plasminogen) (5)
38,000 (val-plasminogen) (6)
Extinction coefficient:
E
1 %
1 c m, 280 nm
= 17.0 (5)
Isoelectric point: 6.2 (glu-plasminogen) (1)
6.7-8.3 (lys-plasminogen) (1)
Structure: single chain, 24 intra chain disulfide bridges, 5 kringle regions.
Percent carbohydrate: Approximately 2%

PURCHASING AND PRODUCT INFORMATION

 

Catalog Number

HCPG-0130

HCPG-0131

HCPG-0132

HCPG-0133

BCPG-1130

MCPG-5130

Description

Human glu-Plasminogen

Human glu-Plasminogen CHOI

Human glu-Plasminogen CHOII

Human lys-Plasminogen

Bovine glu-Plasminogen

Mouse glu-Plasminogen

Size

1 milligram

1 milligram

1 milligram

1 milligram

1 milligram

100 µg

Formulation

50% (vol/vol) glycerol/H2O

Storage

-20oC

Purity

>95% by SDS-PAGE

Activity Determination

< 10 ppm plasmin activity for glu-PG

Shelf Life (properly stored)

12 months

U.S. Pricing

Product inquiry

SAMPLE DATA SHEET

ORDER NOW!

References 

1. Robbins, K.C., Methods in Enzymology, 45, 257 (1976). 
2. Collen, D. in Blood Coagulation, Zwaal, R.E.A. and Hemker, H.C., eds., pp. 243-258, New York, Elsevier (1986). 
3. Castellino, F.J., et al., Methods in Enzymology, 80, 365 (1981). 
4. Wohl, R.C., et al., Thromb. Res., 27 523 (1982). 
5. Barlow, G.H., et al., Biochemistry, 23, 2384 (1984). 
6. Sottrup-Jensen, L., et al., in Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 3, ed. J.F. Davidson, 7. R.M. Rowan, M.M. Samana, P.C. Desnoyers, pp. 197-228, New York: Raven Press (1975). 

 

PRODUCTS ORDERING SERVICES ABOUT US TECH NOTES CONTACT

 

© 2009 Haematologic Technologies, Inc. All Rights Reservedspacer